CLOPIDOGREL VS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS

这是一项三盲、随机化研究，有两个平行组： 氯吡格雷每日75 mg vs阿司匹林325 mg。 这项研究将让人们 在随机化后六个月内中风的患者， 他们三年来评估氯吡格雷与 阿司匹林降低缺血性脑卒中复合结局的发生率 以及两种药物的相对安全性和耐受性。

This is a triple-blind, randomized study with two parallel groups: Clopidogrel 75 mg daily vs aspirin 325 mg. The study will take people who have had strokes within six months of randomization and will follow them for three years to assess the relative efficacy of Clopidogrel vs aspirin in reducing the incidence of the composite outcome of ischemic stroke, as well as the relative safety and tolerability of the two drugs.